Fluoxetine may decrease anxiety, improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. How to use Fluoxetine DR. Read the Medication Guide. While most SSRI drugs should be tapered, Prozac (fluoxetine) has an extremely long half-life decreasing by as little as 10 mg is unlikely to cause withdrawal. Fluoxetine is also sometimes used to treat alcoholism, attention-deficit disorder, borderline personality disorder, sleep disorders, headaches, mental illness, posttraumatic stress disorder, Tourette's syndrome, obesity, sexual problems, and phobias. A: Unfortunately, a common side effect of Prozac (the generic is fluoxetine) and other SSRIs (selective seratonin reuptake inhibitors) like it is a decrease in sex drive. Depression can also. Medscape - Depression, obsessive-compulsive disorder, premenstrual dysphoric disorder-specific dosing for Prozac, Sarafem (fluoxetine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant. Fluoxetine affects chemicals in the brain that may be unbalanced in people with depression, panic, anxiety, or obsessive-compulsive symptoms. Fluoxetine is frequently used to treat major depressive disorder, obsessive–compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bulimia nervosa, panic disorder, premenstrual dysphoric disorder, and trichotillomania. Introduction. The presence of pharmaceutical drugs in the aquatic environment is a significant concern to regulatory agencies because these drugs could affect both the human population and aquatic ecosystems. A decrease in ADP and ristocetin-induced platelet aggregation in a patient treated with fluoxetine was also reported by Evans et al. They also described an increase in bleeding time to more than 25 minutes, with positive dechallenge and rechallenge. 46 -Fluoxetine is not approved for use in children less than 7 years of age. Safety and efficacy have not been established in pediatric patients younger than 7 years (OCD) and 8 years of age (MDD). Safety and efficacy in the treatment of PMDD have not been established in pediatric patients.